Evaluation Only. Created with Aspose.PDF. Copyright 2002-2021 Aspose Pty Ltd.
Vol. 26, No. 15 (2014)
Synthesis and Antibacterial Assay of 9-Substituted Aryl-1,8-dioxo-octahydroxanthenes 4595
mixture was heated up to 90 °C to evolve reddish brown gases
and became dried gel, which was finally treated at 350 °C for
1 h to observe whether the dry gel burnt out in self propagating
manner to form loose powder. The finely powdered particles
were calcinated at 600 °C. The powder was then characterized.
General method of synthesis of 9-substituted aryl-1,8-
dioxo-octahydroxanthenes: A mixture of 5,5-dimethyl-1,3-
cyclohexanedione (2eq) (1), substituted aromatic aldehydes
(1 eq) (2) and CuFe2O4 nano particles (15 mol %) were stirred
at 120 °C in an oil bath for the time indicated in Table-1. The
completion of the reaction was monitored by TLC.After comp-
letion of the reaction, the reaction was cooled to room tempe-
rature and a solid product was obtained. The product was
dissolved in methanol and the catalyst was recovered by
magnetization. The crude products were further purified by
recrystallization from ethanol. All the synthesized products
were characterized by IR, NMR and Mass spectroscopic data
and their melting points were compared with authentic samples.
The reaction times, percentage of yield and m.p.’s were presented
in Table-1. The spectral data of the synthesized compounds
(3a-3j) are given below.
126.93, 128.91,129.12, 129.88, 131.03, 131.23, 131.58,
143.98, 148.65; MS (m/e, %) 437 (20), 281 (100), 252 (40),
75 (15).
Compound(3i): 9-(4-Nitrophenyl)-3,3,6,6-tetramethyl-
1,2,3,4,5,6,7,8-octahydroxanthene-1,8-dione m.p. 219-221 °C.
IR (KBr, νmax, cm-1): 2958, 1670, 1650, 1520, 1362, 1206,
870. 1H NMR (400 MHz, CDCl3): δ 8.09 (d, J = 8.0 Hz, 2H,
ArH), 7.46 (d, J = 8.0 Hz, 2H, ArH), 4.82 (s, 1H, CH), 2.49
(s, 4H, 2CH2), 2.21 (q, J = 16.2 Hz, 4H, 2CH2), 1.12 (s, 6H,
2CH3), 0.99 (s, 6H, 2CH3). 13C NMR (75 MHz, CDCl3): δ
196.1,162.9, 151.3, 146.6, 129.4, 123.5, 114.5, 50.5, 40.8,
32.3, 32.1, 29.6,29.2, 27.2. MS (m/e): 395 (M+). Anal. Calcd
for C23H25NO5: C, 69.85; H, 6.37; N, 3.54. Found: C, 69.96; H
6.49; N, 3.43.
Antibacterial assay: Antibacterial studies were carried
out on human pathogenic bacteria. Salmonella typhi, Vibrio
cholerae, Shigella dysenteriae and Enterococcus faecalis,
which were clinical isolates collected at King George Hospital,
Visakhapatnam, India. S. typhi, V. cholerae, S. dysenteriae and
E. faecalis are gastrointestinal pathogens.Antibacterial activity
was performed by agar well diffusion method and minimum
inhibitory concentration (MIC)27,28.Agar well diffusion method
was performed to determine the inhibitory zones in millimeter
(mm). MIC was determined by broth dilution assay and the
experiment was conducted between 1-1000 µg/mL of compound
concentration. Ciprofloxacin (antibiotic) and DMSO were used
as positive control and negative control respectively29.
Molecular docking studies: X-ray crystal structures of
proteins used in docking studies are obtained from Protein
Data Bank. Topoisomerase I (PDB ID 1T8I) was used in docking
studies. Co-cystalized ligands and water molecules are removed
from target protein usingArgus lab. Ligands are prepared using
Chemoffice (Cambridge). Energy minimization was done
using molecular mechanics. The minimized was executed until
root mean square value reached smaller than 0.001 Kcal/mol.
Such energy minimized ligands and receptor used for docking
studies using GEMDOCK (Generic Evolutionary Method for
molecular docking) is a generic evolutionary method with an
empirical scoring function for the protein-ligand docking,
which is a problem of paramount importance in structure-based
drug design, combines both continuous and discrete search
mechanisms. A population size of 300 with 70 generations
Spectral data for selected compounds
Compound (3a): 9-Phenyl-3,3,6,6-tetramethyl-1,2,3,4,5,
6,7,8-octahydroxanthene-1,8-dione m.p. 204-205 °C. IR (KBr,
1
ν
max, cm-1): 2954,1664,1364,1199. H NMR (400 MHz,
CDCl3): δ 7.27-7.09 (m, 5H, ArH), 4.74 (s, 1H, C9-H), 2.46
(s, 4H, 2CH2), 2.19 (q, J = 16.5 Hz, 4H, 2CH2), 1.10 (s, 6H,
13
2CH3), 0.98 (s, 6H, 2CH3). C NMR (100 MHz, CDCl3): δ
196.2, 162.3, 143.8, 128.4, 127.6, 115.2, 50.6, 40.7, 32.0, 31.6,
29.3, 27.2. MS (m/e): 350 (M+). Anal. Calcd for C23H26O3:
C, 78.83; H, 7.47. Found: C, 78.96; H, 7.40.
Compound (3b): 9-(4-Methylphenyl)-3,3,6,6-tetramethyl-
1,2,3,4,5,6,7,8-octahydroxanthene-1,8-dione. m.p. 215-
217 °C. IR (KBr, νmax, cm-1): 3030, 2980, 1685, 1660, 1620,
1490, 1365, 1200, 1135, 1000, 850, 840. 1H NMR (400 MHz,
CDCl3): δ 7.16 (d, J = 8.0Hz, 2H, Ar H), 7.01 (d, J = 8.0 Hz,
2H, ArH), 4.70 (s, 1H, CH), 2.45 (s, 4H, 2CH2), 2.23 (s, 3H,
CH3), 2.19 (q, J = 16.3 Hz, 4H, 2CH2), 1.09 (s, 6H, 2CH3),
0.99 (s, 6H, 2CH3).13C NMR (100 MHz, CDCl3): δ 196.4,
162.1, 141.1, 135.7, 128.7, 128.1,115.7, 50.7, 40.8, 32.1, 31.3,
29.2, 27.3, 20.9. MS (m/e): 364 (M+).Anal.Calcd for C24H28O3:
C, 79.09; H, 7.74. Found: C, 79.16; H 7.49.
and three solutions were used, in docking accuracy setting30,31
.
Compound (3c): 9-(4-Hydroxyphenyl)-3,3,6,6-tetra-
methyl-1,2,3,4,5,6,7,8-octahydroxanthene-1,8-dione. m.p.
220-222 °C. IR (KBr, νmax, cm-1): 3324, 2959, 1652, 1617,
1363. 1H NMR (400 MHz, CDCl3): δ 7.10 (d, J = 8.4 Hz, 2H,
Ar H), 6.60 (d, J = 8.4 Hz, 2H, Ar H), 5.72 (s, 1H, OH, D2O
exchangeable), 4.67 (s, 1H, CH), 2.45 (s, 4H, 2CH2), 2.20 (q,
J = 16.2 Hz, 4H, 2CH2), 1.09 (s, 6H, 2CH3), 0.99 (s, 6H, 2CH3).
13C NMR (75 MHz, CDCl3): δ 195.8, 162.5, 140.7, 135.5,
128.2, 128.0,115.2, 50.6, 40.1, 32.4, 31.2, 29.1, 27.2. MS
(m/e): 366 (M+). Anal.Calcd for C23H26O4: C, 75.38; H, 7.15.
Found: C, 75.16; H 7.29.
RESULTS AND DISCUSSION
In continuation of our interest in the area of clean synthesis,
under solvent-free conditions, for the development of new
synthetic methodologies herein, we report a simple, efficient
and one-pot reaction of dimedone and aldehydes using nano
copper ferrite at 120 °C for the preparation of 9-substituted
aryl-1,8-dioxo-octahydroxanthenes (3a-3j) in high yields
(Scheme-I) and the results were presented in Table-1.
Initially, a blank reaction using benzaldehyde and dimedone
(mole rate 1:2) at 120 °C without nano copper ferrite was per-
formed in order to establish the real effectiveness of the catalyst
and the results showed that desired product was not formed
even after 12 h of heating. We then focused to optimize catalyst
loading percentage. In order to evaluate the most appropriate
Compound (3g): 9-(4-Bromophenyl)-3,3,6,6-tetramethyl-
1,2,3,4,5,6,7,8-octahydroxanthene-1, 8-dione. m.p. 230-232 °C;
IR (KBr, νmax, cm-1): 3030, 1624, 1586; 1H NMR (400 MHz,
CDCl3): δ 6.47 (1H, s, CH),7.25-8.34 (m, 4H,ArH.); 13C NMR
(CDCl3): δC 37.46,116.64, 118.02, 120.21, 122.39, 124.38,